US2011033929A1PendingUtilityA1

Uses of antibodies to mammalian dc langerhans cell antigen

Assignee: DUVERT-FRANCES VALERIEPriority: Sep 25, 1998Filed: Sep 2, 2008Published: Feb 10, 2011
Est. expirySep 25, 2018(expired)· nominal 20-yr term from priority
C07K 16/2851C07K 14/705
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to purified mammalian DC cell surface protein, designated Langerin, nucleic acids encoding Langerin, and antibodies which specifically bind Langerin.

Claims

exact text as granted — not AI-modified
1 - 15 . (canceled) 
     
     
         16 . An antibody conjugate comprising: an antibody or antigen binding fragment thereof which specifically binds to a polypeptide comprising the amino acid of SEQ ID NO: 2 conjugated to an antigen. 
     
     
         17 . The antibody conjugate of  claim 16 , wherein said antibody or antigen binding fragment thereof is a monoclonal antibody or an antigen binding fragment thereof. 
     
     
         18 . The antibody conjugate of  claim 17 , wherein said monoclonal antibody or antigen binding fragment thereof is the monoclonal antibody having ATCC Accession No. HB-12576 or an antigen binding fragment thereof. 
     
     
         19 . A method of targeting antigen to dendritic cells comprising the use of an antibody conjugate, said antibody conjugate comprising an antibody or antigen binding fragment thereof which specifically binds to a polypeptide comprising the amino acid of SEQ ID NO: 2 conjugated to an antigen. 
     
     
         20 . The method of  claim 19 , wherein said antibody or antigen binding fragment thereof is a monoclonal antibody or an antigen binding fragment thereof. 
     
     
         21 . The method of  claim 20 , wherein said monoclonal antibody or antigen binding fragment thereof is the monoclonal antibody having ATCC Accession No. HB-12576 or an antigen binding fragment thereof.

Join the waitlist — get patent alerts

Track US2011033929A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.